This will calm the farm. A very good report indeed.
# Revenues nearly trebled from PCP while personnel costs actually went down.
# Gross Margin 49%....Magnificent margins for a startup.....Their pharmaceuticals has the highest margins of 52%.
# +ve cash flow after investing $1.3 to double manufacturing capacity to $57m.
# $3.3m EBITDA +ve.
# Strong working capital.....Working Capital doubled to $5m from the June half...... Well funded internally.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.004(12.9%) |
Mkt cap ! $58.45M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.2¢ | 2.7¢ | $249.2K | 8.379M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1096318 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 150000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| BXN (ASX) Chart |